Roles of ALL FIT Members
OUR Board of Advisors:
TBD
OUR Board Members:
- Dr. Larry H. Bernstein, MD, FCAP – Medical Leave
- Prof. Marcus W. Feldman
- Stephen J Williams – Pending
OUR Founder:
- Aviva Lev-Ari, PhD, RN
OUR Scientists are:
- Justin D. Pearlman, MD/PhD, FACC
- Stephen J. Williams, PhD
- Tilda Barliya, PhD
- Irina Robu, PhD
- Dror Nir, PhD
- Ritu Saxena, PhD
- Sudipta Saha, PhD
- Adam Sonnenberg [2019 – MD/PhD student, Since LPBI days (5/2015), Completed format conversion in 2015 for 7 e-Books. June 2019 – RA to Aviva]
OUR Business Team include:
- Gail – Marketing Communications
- Amnon – Strategy
- Rick – Business Development & Marketing: Digital Published Products
External Affiliations
- Medical Doctors: Dr. Larry H. Bernstein (retired), Dr. Pearlman (Central Maine Medical Center)
- Doctors of Philosophy: Dr. Pearlman, Dr. Williams, Dr. Saha, Dr. Saxena, Dr. Barliya, Dr. Robu, Dr. Nir, Dr. Lev-Ari
- Professors in Academia: Prof. Marcus W. Feldman (Stanford University), Prof. Stephen J. Williams (Temple University), Prof. Sudipta Saha (Amity University Noida, Uttar Pradesh, India), Dr. Irina Robu (Windsor, Ontario, Canada), Adam Sonnenberg, PhD(c), Boston University
- Executives in the biotechnology industry: Gail S. Thornton (Merck USA), Ritu Saxena (Astellas Pharma)
- Executives in high tech industries: Rick Mandahl, Amnon Danzig
FIT members – Who works on WHAT?
UPDATED on 3/25/2019
| Scientists | Tasks for ALL FIT MEMBERS – UPDATED on 3/24/2019
· UPDATE their CV on the Journal [Completion on 5/15/2019] · New Posts per Commissions to keep Journal ALIVE [Ongoing, EACH SCIENTIST needs to initiate NEW posts and posy per Commissions] · Attend Skypes with FIT members [Sessions are 2 hours long] · Attend Skypes with Investment Banker, as needed · Retweet for · @AVIVA1950 · @pharma_BI · IMPLEMENT GAIL’s Tips for Twitter.com [Ongoing] |
FIT Member’s Progress Report – self documented inside Scientist’s cell | Aviva provides
1. Feedbacks and 2. Defines and Assigns new tasks as needed for Request For Information (RFI) by Investment Banker (IB) |
|
| Dr. Pearlman | IP Valuation Model for Intangibles – work with Aviva
[Concept implementation Will start in May 2019] Please Skype with Aviva ASAP |
|||
| Dr. Williams | 1. Update last 10 articles of SJW & LHB
[Progress report DUE] 2. Reconnect to Social Media [Ongoing] 3. New Posts per Commissions [Ongoing] 4. Review and comments on Section #13 [Progress report DUE] ____________________ |
|||
| Dr. Barliya | 1. Update last 10 articles of TB & LHB’s 10 before last 10
[Progress report DUE] 2. Reconnect to Social Media of own past posts [Progress report DUE] 3. New Posts per Commissions [Ongoing] _________________ |
|||
| Dr. Robu | 1. Weekly Articles Update per list from Aviva
[Progress report DUE] 2. Update last 10 articles of Irina & LHB 20 to 30 lasts [Progress report DUE] 3. New Posts per Commissions [Ongoing] ____________________ |
|||
| Dr. Nir | 1. Update last 10 articles of Dror Nir
[Progress report DUE] 2. New Posts per Commissions [Ongoing] ___________________ |
|||
| Dr. Saxena | 1. SumAll
[Not addressed yet] 2. Collapse Categories [Ongoing] 3. Valuation Model of the Journal, Scoring each Article [Not addressed yet] _______________ |
|||
| Dr. Saha | 1. Update last 10 articles of S. Saha
[Progress report DUE] 2. Reconnect to Social Media [Ongoing] 3. New Posts per Commissions [Ongoing] _________________ |
|||
| Aviva | 1. Forecasting Model per e-Series
2. BioMed eReaders behavior on Amazon – 16 Files 3. Architecture of Positioning Model – to send to IB 4. IP Valuation Model for Intangibles – work with Dr. Pearlman 5. Tweeter Filtering @pharma_Bi for Total Followers’ Followers 6. Identifying Most Honored to be followed by for Tweets by ALL FIT members 7. Sending IB intermediate results 8. Schedule Skype sessions with FIT Members 9. Schedule Skype sessions with IB 10. Schedule Skype sessions with business tycoons in Global markets _______________ |
|||
| Prof. Marc Feldman – Member of the Board | 1. Review Aviva’s Final Reports for editorial and comments [Ongoing]
2. Advice per RFI [Ongoing] 3. Attend Meetings with IB [To be Scheduled] 4. Attend selective meetings with FIT Members per topic [To be Scheduled] _________________ |
|||
| Bus DEV & Marketing Digital Published Products | ||||
| Rick | 1. Competitive Space of LPBI [submitted to Aviva’s satisfaction]
2. Market Plan for +60 Biotech e-Proceedings [PENDING] 3. Journal Subscribers List from WordPress [PENDING] 4. Identify markets for eSeries [PENDING] ________________ |
|||
| AMNON | · Tweeter IMPLEMENT GAIL’s Tips
@pharma_BI @AVIVA1950 [PENDING] Aviva’s 1st level Connections in Biotech/Pharma & Publishing and VC – Global [PENDING] 2. Aviva’s 1st level Connections in Biotech/Pharma and VC – Israel [PENDING] _____________ |
|||
| GAIL
Marketing Communication
|
Gail’s Progress Report on Assigned Tasks, 4/14/2019:
|
|||
Original Created on March 4, 2019
| Scientists | Tasks for ALL FIT MEMBERS
· UPDATE their CV on the Journal · New Posts per Commissions to keep Journal ALIVE · Attend Skypes with FIT members · Attend Skypes with Investment Banker, as needed · Retweet for · @AVIVA1950 · @pharma_BI · IMPLEMENT GAIL’s Tips
|
FIT Member’s Progress Report – self documented inside Scientist’s cell | Aviva provides
1. Feedbacks and 2. Defines and Assigns new tasks as needed for Request For Information (RFI) by Investment Banker (IB) |
|
| Dr. Pearlman | IP Valuation Model for Intangibles – work with Aviva
|
|||
| Dr. Williams | 1. Update last 10 articles of SJW & LHB
2. Reconnect to Social Media 3. New Posts per Commissions |
|||
| Dr. Barliya | 1. Update last 10 articles of TB & LHB’s 10 before last 10
2. Reconnect to Social Media 3. New Posts per Commissions |
|||
| Dr. Robu | 1. Weekly Articles Update per list from Aviva
2. Update last 10 articles of Irina & LHB 20 to 30 lasts 3. New Posts per Commissions |
|||
| Dr. Nir | 1. Update last 10 articles of Dror Nir
2. New Posts per Commissions |
|||
| Dr. Saxena | 1. SumAll
2. Collapse Categories 3. Valuation Model of the Journal, Scoring each Article |
|||
| Dr. Saha | 1. Update last 10 articles of S. Saha
2. Reconnect to Social Media 3. New Posts per Commissions |
|||
| Aviva | 1. Forecasting Model per e-Series
2. BioMed eReaders behavior on Amazon – 16 Files 3. Architecture of Positioning Model – to send to IB 4. IP Valuation Model for Intangibles – work with Dr. Pearlman 5. Tweeter Filtering @pharma_Bi for Total Followers’ Followers 6. Identifying Most Honored to be followed by for Tweets by ALL FIT members 7. Sending IB intermediate results 8. Schedule Skype sessions with FIT Members 9. Schedule Skype sessions with IB 10. Schedule Skype sessions with business tycoons in Global markets |
|||
| Prof. Marc Feldman – Member of the Board | 1. Review Aviva’s Final Reports for editorial and comments
2. Advice per RFI 3. Attend Meetings with IB 4. Attend selective meetings with FIT Members per topic |
|||
| Bus DEV & Marketing Communication | ||||
| Rick | 1. Competitive Space of LPBI
2. Market Plan for +60 Biotech e-Proceedings 3. Journal Subscribers List from WordPress 4. Identify markets for eSeries |
|||
| Amnon | · Tweeter – IMPLEMENT GAIL’s Tips
@pharma_BI @AVIVA1950 1. Aviva’s 1st level Connections in Biotech and VC – Global 2. Aviva’s 1st level Connections in Biotech and VC – Israel |
|||
| GAIL
Marketing Communication
|
|
|||
Roles of ALL FIT Members
OUR Board Members:
- Larry – Medical Leave
- Feldman
OUR Scientists are:
- Justin
- Williams
- Tilda
- Irina
- Dror Nir
- Ritu
- Saha
- Adam [2019 – MD/PhD since LPBI days (2015), Completed format conversion in 2015 for 7 e-Books]
OUR Business Team include:
- Gail – Marketing Communications
- Amnon – Strategy
- Rick – Marketing
2012pharmaceutical
Aashir Awan, Phd
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
amnondanzig1724
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
evelinacohn
Gail S Thornton
Irina Robu
jdpmd
kellyperlman
Ed Kislauskis
larryhbern
lmulligan13gmailcom
marzankhan
megbaker58
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
sjwilliamspa
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22